SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-23-000273
Filing Date
2023-01-09
Accepted
2023-01-09 08:15:57
Documents
14
Period of Report
2023-01-09
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K apvo-8k_20230109.htm   iXBRL 8-K 35158
2 EX-99.1 apvo-ex991_6.htm EX-99.1 15320
3 GRAPHIC gxvbxob4km3g000001.jpg GRAPHIC 2804
  Complete submission text file 0001564590-23-000273.txt   187846

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA apvo-20230109.xsd EX-101.SCH 5629
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE apvo-20230109_lab.xml EX-101.LAB 19333
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE apvo-20230109_pre.xml EX-101.PRE 11520
8 EXTRACTED XBRL INSTANCE DOCUMENT apvo-8k_20230109_htm.xml XML 3537
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

IRS No.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37746 | Film No.: 23516720
SIC: 2834 Pharmaceutical Preparations